COH04S1

COH04S1 is a covid vaccine developed by the City of Hope Medical Center.

Uses your system voice; voice and rate in settings.

≈ 3 min read

Cite, export and learn8 citation formats · 8 exports · lesson and quiz

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

COH04S1 is a covid vaccine developed by the City of Hope Medical Center. This vaccine targets patients who are immunocompromised; immunocompromised patients have often shown a weak antibody response to past COVID-19 vaccines. COH04S1 is also targeted on people who are at a high risk of COVID-19 complications.

The City of Hope Medical Center strives to make a better option than the current EUA and FDA approved vaccines, which are not working as well on this group of individuals. The group leading the investigation of the vaccine is led by scientists named Felix Wussow with a Ph.D., Flavia Chiuppesi with a Ph.D. as well, them both City of Hope assistant research professors in the Department of Hematology & Hematopoietic Cell Transplantation.

The leader is named Don J. Diamond, Ph.D.: professor in the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope. The vaccine is the first to study the safety and effectiveness in patients that have received a bone marrow transplant or chimeric antigen receptor therapy.

It is also the first to look at the differences between the Pfizer vaccine with one that accommodates people who are receiving immunosuppressive therapy. Previous COVID-19 vaccines in blood cancer patients show a high probability that 1 out of 4 blood cancer patients fail to produce antibodies.

COH04S1 hopes to lower the chances of failure in producing antibodies in blood cancer patients. This vaccine is built on a FDA-approved platform known as modified vaccinia ankara, also known as MVA. This platform has famously been used safely worldwide and effectively in cancer and transplant patients.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1276644627 under CC BY-SA 4.0; modifications have been made.

Provenance

snapshot enwiki-001276644627 · captured 2025-02-19 · ledger · version history

Cite this page as: encyclopegia.org, “COH04S1”, snapshot enwiki-001276644627. https://encyclopegia.org/a/coh04s1

Sources cited in this revision

1 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.